Investor profile
Invest-NL has backed 60 European tech companies across 75 funding rounds between 2020 and 2026, joining rounds totalling €2.3B. Most active in Healthtech and Energy. Data as of 21 Sept 2026.
Also recorded as: Invest NL · Invest‑NL · InvestNL
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Nearfield Instruments | Netherlands | 5 | €511M |
| RIFT | Netherlands | 2 | €125M |
| Leyden Labs | Netherlands | 2 | €110M |
| ViCentra | Netherlands | 2 | €83M |
| Lightyear | Netherlands |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Nearfield Instruments | Series D+ | €332M | 2026-06 |
| Nearfield Instruments | Series C | €135M | 2024-07 |
| RIFT | Series B | €114M | 2026-03 |
| Lightyear |
| 1 |
| €81M |
| Vitestro | Netherlands | 2 | €80M |
| BioBTX | Netherlands | 1 | €80M |
| Axelera AI | Netherlands | 1 | €64M |
| Mosa Meat | Netherlands | 2 | €55M |
| Salvia BioElectronics | Netherlands | 1 | €53M |
| Xeltis | Switzerland | 2 | €51M |
| Protix | Netherlands | 1 | €50M |
| Fairphone | Netherlands | 1 | €49M |
| The Protein Brewery | Netherlands | 2 | €48M |
| Leydenjar | Netherlands | 2 | €45M |
| Microsure | Netherlands | 2 | €41M |
| Onera Health | Netherlands | 2 | €41M |
| eyeo | Netherlands | 1 | €40M |
| EFFECT Photonics | Netherlands | 1 | €38M |
| October | France | 1 | €35M |
| Thorizon | Netherlands | 2 | €33M |
| Vivici | Netherlands | 1 | €32M |
| Meatable | Netherlands | 1 | €32M |
| Battolyser Systems | Netherlands | 1 | €30M |
| iwell | Netherlands | 1 | €27M |
| Onward | Netherlands | 1 | €27M |
| revyve | Netherlands | 1 | €24M |
| Qorium | Netherlands | 1 | €22M |
| AMT Medical | Netherlands | 1 | €22M |
| Keiron Printing Technologies | Netherlands | 1 | €21M |
| Other |
| €81M |
| 2022-09 |
| BioBTX | Other | €80M | 2024-06 |
| ViCentra | Series D+ | €73M | 2025-09 |
| Axelera AI | Other | €64M | 2024-06 |
| Vitestro | Series B | €60M | 2026-03 |
| Salvia BioElectronics | Series B | €53M | 2025-05 |
| Protix | Other | €50M | 2022-02 |
